英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
irbis查看　irbis　在百度字典中的解释百度英翻中〔查看〕
irbis查看　irbis　在Google字典中的解释Google英翻中〔查看〕
irbis查看　irbis　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • General Clinical Practice Use of Nadofaragene Firadenovec . . .
    Practical Considerations for Nadofaragene Firadenovec Use e firadenovec, including administration, monitoring, supportive care, and patient education Successful instillation of nadofaragene fir denovec requires understanding its transportation, storage, and administration requirements While urolo-gy clinics and ealth car Figure 1
  • Package Insert and Information for Patients - Adstiladrin
    11 DESCRIPTION ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation
  • Dosing | ADSTILADRIN® (nadofaragene firadenovec-vncg)
    Find information on the dosing and administration of ADSTILADRIN®, including instillation details See Important Safety Info
  • Full article: Budget impact model of nadofaragene firadenovec . . .
    Methods A budget impact model was developed to compare total healthcare costs under two scenarios: (1) with nadofaragene firadenovec included in the treatment mix, and (2) without it The model simulated a hypothetical US health plan covering one million members over a 3-year time horizon Costs assessed included drug acquisition and administration, surveillance and disease management
  • Nadofaragene Firadenovec-vncg Monograph for Professionals . . .
    After the instillation, allow nadofaragene firadenovec-vncg to be left in the bladder for 1 hour During the 1 hour dwell time, the patient should reposition approximately every 15 minutes See Full Prescribing information for additional instructions on preparation and administration of nadofaragene firadenovec-vncg
  • Nadofaragene firadenovec-vncg (urinary bladder route)
    Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor
  • Medical Policy Adstiladrin (nadofaragene firadenovec-vncg)
    Summary of Evidence Nadofaragene firadenovec-vncg, a non-replicating adenoviral vector gene therapy delivering the interferon-alpha-2b gene, has emerged as a novel treatment for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) Key clinical evidence comes from three major studies: Dinney et al (2013) performed a dose-ascending phase I trial, and Shore et
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
    ADSTILADRIN® is the first and only FDA-approved gene therapy for treating adult patients with high-risk BCG-unresponsive NMIBC See Important Safety Info
  • Oncology Drug Reference Sheet: Nadofaragene Firadenovec-Vncg
    Under the U S Food and Drug Administration’s (FDA’s) fast-track approval process, nadofaragene firadenovec-vncg (Adstiladrin®) became the first gene therapy approved for the treatment of high-risk non-muscle invasive bladder cancer Approximately 75% of newly diagnosed bladder cancers are classified as non-muscle invasive Bacillus Calmette Guérin has been used as first-line therapy for
  • Adstiladrin | European Medicines Agency (EMA)
    Nadofaragene firadenovec is a non-replicating, recombinant type 5 adenovirus vector-based gene therapy containing the human IFNα2b transgene Its intravesical administration results in the entry of viral particles into the tumour cells and the urothelium of the bladder, leading to the expression of the IFNα2b protein in such cells, which in





中文字典-英文字典  2005-2009